{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T02:14:54Z","timestamp":1788488094715,"version":"build-2803163510"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:00:00Z","timestamp":1788480000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:00:00Z","timestamp":1788480000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Immunol Res"],"DOI":"10.1007\/s12026-026-09803-0","type":"journal-article","created":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T02:11:21Z","timestamp":1788487881000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["SIX1 drives acute myeloid leukemia progression by reprogramming glycolytic metabolism and impairing CD8\u207a T-cell effector function"],"prefix":"10.1007","volume":"74","author":[{"given":"Hui","family":"Hou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruijun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junli","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luqiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,4]]},"reference":[{"issue":"3","key":"9803_CR1","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1002\/ajh.26822","volume":"98","author":"S Shimony","year":"2023","unstructured":"Shimony S, Stahl M, Stone RM. Acute myeloid leukemia: 2023 update on diagnosis, risk-stratification, and management [J]. Am J Hematol. 2023;98(3):502\u201326.","journal-title":"Am J Hematol"},{"issue":"2","key":"9803_CR2","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1159\/000536152","volume":"147","author":"F Wachter","year":"2024","unstructured":"Wachter F, Pikman Y. Pathophysiology of Acute Myeloid Leukemia [J]. Acta Haematol. 2024;147(2):229\u201346.","journal-title":"Acta Haematol"},{"issue":"1","key":"9803_CR3","first-page":"10","volume":"75","author":"RL Siegel","year":"2025","unstructured":"Siegel RL, Kratzer TB, Giaquinto AN, et al. Cancer statistics, 2025. CA Cancer J Clin. 2025;75(1):10\u201345.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"9803_CR4","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s10585-022-10189-0","volume":"40","author":"R Mecklenbrauck","year":"2023","unstructured":"Mecklenbrauck R, Heuser M. Resistance to targeted therapies in acute myeloid leukemia [J]. Clin Exp Metastasis. 2023;40(1):33\u201344.","journal-title":"Clin Exp Metastasis"},{"issue":"2","key":"9803_CR5","doi-asserted-by":"publisher","first-page":"353","DOI":"10.3324\/haematol.2022.280800","volume":"108","author":"P Stelmach","year":"2023","unstructured":"Stelmach P, Trumpp A. Leukemic stem cells and therapy resistance in acute myeloid leukemia [J]. Haematologica. 2023;108(2):353\u201366.","journal-title":"Haematologica"},{"issue":"4","key":"9803_CR6","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1158\/2643-3230.BCD-23-0202","volume":"5","author":"C Restelli","year":"2024","unstructured":"Restelli C, Ruella M, Paruzzo L, et al. Recent Advances in Immune-Based Therapies for Acute Myeloid Leukemia [J]. Blood cancer discovery. 2024;5(4):234\u201348.","journal-title":"Blood cancer discovery"},{"key":"9803_CR7","doi-asserted-by":"crossref","unstructured":"Sendker S. Reinhardt D, Niktoreh N. Redirecting the Immune Microenvironment in Acute Myeloid Leukemia [J]. Cancers. 2021;13(6).","DOI":"10.3390\/cancers13061423"},{"issue":"1","key":"9803_CR8","doi-asserted-by":"publisher","first-page":"46","DOI":"10.3322\/caac.21873","volume":"75","author":"HM Kantarjian","year":"2025","unstructured":"Kantarjian HM, Dinardo CD, Kadia TM, et al. Acute myeloid leukemia management and research in 2025 [J]. Cancer J Clin. 2025;75(1):46\u201367.","journal-title":"Cancer J Clin"},{"issue":"5","key":"9803_CR9","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1002\/ajh.27625","volume":"100","author":"S Shimony","year":"2025","unstructured":"Shimony S, Stahl M, Stone RM. Acute Myeloid Leukemia: 2025 Update on Diagnosis, Risk-Stratification, and Management [J]. Am J Hematol. 2025;100(5):860\u201391.","journal-title":"Am J Hematol"},{"issue":"1","key":"9803_CR10","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1186\/s12967-023-04679-2","volume":"21","author":"L Guo","year":"2023","unstructured":"Guo L, Li F, Liu H, et al. SIX1 amplification modulates stemness and tumorigenesis in breast cancer [J]. J translational Med. 2023;21(1):866.","journal-title":"J translational Med"},{"issue":"7","key":"9803_CR11","doi-asserted-by":"publisher","first-page":"4523","DOI":"10.1111\/jcmm.14342","volume":"23","author":"Y Zhang","year":"2019","unstructured":"Zhang Y, Wang S, Liu Z, et al. Increased Six1 expression in macrophages promotes hepatocellular carcinoma growth and invasion by regulating MMP-9 [J]. J Cell Mol Med. 2019;23(7):4523\u201333.","journal-title":"J Cell Mol Med"},{"key":"9803_CR12","doi-asserted-by":"crossref","unstructured":"Meng M, Guan G, Liu X et al. miR-7160 inhibits gastric cancer cell proliferation and metastasis by silencing SIX1 [J]. J Genet. 2024;103.","DOI":"10.1007\/s12041-024-01479-5"},{"issue":"3","key":"9803_CR13","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1093\/carcin\/bgw121","volume":"38","author":"H Xu","year":"2017","unstructured":"Xu H, Zhang Y, Pe\u00f1a MM, et al. Six1 promotes colorectal cancer growth and metastasis by stimulating angiogenesis and recruiting tumor-associated macrophages [J]. Carcinogenesis. 2017;38(3):281\u201392.","journal-title":"Carcinogenesis"},{"key":"9803_CR14","doi-asserted-by":"publisher","first-page":"107327482412717","DOI":"10.1177\/10732748241271714","volume":"31","author":"T Ali","year":"2024","unstructured":"Ali T, Usman R, Shah SA, et al. Aberrant HIF1- \u03b1 and SIX-1 Expression is Associated with Poor Prognosis in Acute Myeloid Leukemia Patients with Isocitrate Dehydrogenase 1 Mutations [J]. Cancer control: J Moffitt Cancer Cent. 2024;31:10732748241271714.","journal-title":"Cancer control: J Moffitt Cancer Cent"},{"issue":"Pt 4","key":"9803_CR15","doi-asserted-by":"publisher","first-page":"142666","DOI":"10.1016\/j.ijbiomac.2025.142666","volume":"308","author":"Y Jin","year":"2025","unstructured":"Jin Y, Xie X, Li H, et al. The role of homeobox gene Six1 in cancer progression and its potential as a therapeutic target: A review [J]. Int J Biol Macromol. 2025;308(Pt 4):142666.","journal-title":"Int J Biol Macromol"},{"key":"9803_CR16","doi-asserted-by":"crossref","unstructured":"Li L, Zhang X, Xu G et al. Transcriptional Regulation of De Novo Lipogenesis by SIX1 in Liver Cancer Cells [J]. Advanced science (Weinheim, Baden-Wurttemberg, Germany). 2024;11(41):e2404229.","DOI":"10.1002\/advs.202404229"},{"key":"9803_CR17","doi-asserted-by":"crossref","unstructured":"Shao Z, Liu S, Sun W, et al. SENP3 mediates deSUMOylation of SIX1 to promote prostate cancer proliferation and migration [J]. Cellular & molecular biology letters. 2024;29(1):146.","DOI":"10.1186\/s11658-024-00665-8"},{"key":"9803_CR18","doi-asserted-by":"crossref","unstructured":"Alberghina L. The Warburg Effect Explained: Integration of Enhanced Glycolysis with Heterogeneous Mitochondria to Promote Cancer Cell Proliferation [J]. Int J Mol Sci 2023;24(21).","DOI":"10.3390\/ijms242115787"},{"key":"9803_CR19","doi-asserted-by":"crossref","unstructured":"Chelakkot C, Chelakkot V S, Shin Y et al. Modulating Glycolysis to Improve Cancer Therapy [J]. Int J Mol Sci. 2023;24(3).","DOI":"10.3390\/ijms24032606"},{"issue":"Pt 3","key":"9803_CR20","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1016\/j.semcancer.2022.09.007","volume":"86","author":"S Paul","year":"2022","unstructured":"Paul S, Ghosh S. Tumor glycolysis, an essential sweet tooth of tumor cells [J]. Sem Cancer Biol. 2022;86(Pt 3):1216\u201330.","journal-title":"Sem Cancer Biol"},{"issue":"3","key":"9803_CR21","doi-asserted-by":"publisher","first-page":"2713","DOI":"10.1007\/s11033-021-06247-7","volume":"48","author":"R Liu","year":"2021","unstructured":"Liu R, Wang X, Shen Y, et al. Long non-coding RNA-based glycolysis-targeted cancer therapy: feasibility, progression and limitations [J]. Mol Biol Rep. 2021;48(3):2713\u201327.","journal-title":"Mol Biol Rep"},{"key":"9803_CR22","doi-asserted-by":"crossref","unstructured":"Bose S, Zhang C. Le A. Glucose Metabolism in Cancer: The Warburg Effect and Beyond [J]. Advances in experimental medicine and biology. 2021;1311:3\u201315.","DOI":"10.1007\/978-3-030-65768-0_1"},{"key":"9803_CR23","doi-asserted-by":"publisher","first-page":"118603","DOI":"10.1016\/j.lfs.2020.118603","volume":"264","author":"M Ghanavat","year":"2021","unstructured":"Ghanavat M, Shahrouzian M, Deris Zayeri Z, et al. Digging deeper through glucose metabolism and its regulators in cancer and metastasis [J]. Life Sci. 2021;264:118603.","journal-title":"Life Sci"},{"issue":"6","key":"9803_CR24","doi-asserted-by":"publisher","first-page":"184","DOI":"10.3892\/ol.2022.13304","volume":"23","author":"H Qi","year":"2022","unstructured":"Qi H, Chen Z, Qin Y, et al. Tanshinone IIA inhibits cell growth by suppressing SIX1-induced aerobic glycolysis in non-small cell lung cancer cells [J]. Oncol Lett. 2022;23(6):184.","journal-title":"Oncol Lett"},{"issue":"24","key":"9803_CR25","doi-asserted-by":"publisher","first-page":"2931","DOI":"10.1182\/blood.2024027496","volume":"146","author":"F Navarro","year":"2025","unstructured":"Navarro F, Lozano T, Fuentes-Garc\u00eda A, et al. Reprogramming glutamine metabolism enhances BCMA-CAR T-cell fitness and therapeutic efficacy in multiple myeloma. Blood. 2025;146(24):2931\u201344.","journal-title":"Blood"},{"key":"9803_CR26","doi-asserted-by":"crossref","unstructured":"Menjivar RE, Nwosu ZC, Du W et al. Arginase 1 is a key driver of immune suppression in pancreatic cancer [J]. eLife,2023, 12.","DOI":"10.7554\/eLife.80721"},{"issue":"2","key":"9803_CR27","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.immuni.2022.01.006","volume":"55","author":"K Hezaveh","year":"2022","unstructured":"Hezaveh K, Shinde RS, KL\u00f6TGEN A, et al. Tryptophan-derived microbial metabolites activate the aryl hydrocarbon receptor in tumor-associated macrophages to suppress anti-tumor immunity. Immunity. 2022;55(2):324-340.e8.","journal-title":"Immunity"},{"issue":"25","key":"9803_CR28","doi-asserted-by":"publisher","first-page":"3518","DOI":"10.1182\/blood.2020008551","volume":"137","author":"M Tcheng","year":"2021","unstructured":"Tcheng M, Roma A, Ahmed N, et al. Very long chain fatty acid metabolism is required in acute myeloid leukemia. Blood. 2021;137(25):3518\u201332.","journal-title":"Blood"},{"issue":"3","key":"9803_CR29","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1007\/s13577-025-01215-w","volume":"38","author":"X Liu","year":"2025","unstructured":"Liu X, Ren H, Wang A, et al. SIX1 enhances aerobic glycolysis and progression in cervical cancer through ENO1 [J]. Hum Cell. 2025;38(3):88.","journal-title":"Hum Cell"},{"issue":"4","key":"9803_CR30","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1158\/2326-6066.CIR-21-0114","volume":"9","author":"J Chen","year":"2021","unstructured":"Chen J. HIF1\u03b1 or HIF2\u03b1: Enhancing CD8(+) T-cell Fitness for Antitumor Immunity [J]. Cancer Immunol Res. 2021;9(4):364.","journal-title":"Cancer Immunol Res"},{"issue":"1","key":"9803_CR31","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.immuni.2022.12.008","volume":"56","author":"J Park","year":"2023","unstructured":"Park J, Hsueh PC, Li Z, et al. Microenvironment-driven metabolic adaptations guiding CD8(+) T cell anti-tumor immunity [J]. Immunity. 2023;56(1):32\u201342.","journal-title":"Immunity"},{"issue":"1","key":"9803_CR32","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1186\/s12967-023-04775-3","volume":"21","author":"J Wu","year":"2023","unstructured":"Wu J, Lu Z, Zhao H, et al. The expanding Pandora\u2019s toolbox of CD8(+)T cell: from transcriptional control to metabolic firing [J]. J translational Med. 2023;21(1):905.","journal-title":"J translational Med"},{"issue":"5","key":"9803_CR33","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/s11864-023-01066-3","volume":"24","author":"RP Gale","year":"2023","unstructured":"Gale RP. Can Immune Therapy Cure Acute Myeloid Leukemia? [J]. Curr Treat Options Oncol. 2023;24(5):381\u20136.","journal-title":"Curr Treat Options Oncol"},{"issue":"9","key":"9803_CR34","first-page":"942","volume":"64","author":"Y Nakazawa","year":"2023","unstructured":"Nakazawa Y. [Immune cell therapy for acute myeloid leukemia] [J]. [Rinsho ketsueki]. Japanese J Clin Hematol. 2023;64(9):942\u20138.","journal-title":"Japanese J Clin Hematol"},{"key":"9803_CR35","doi-asserted-by":"publisher","first-page":"104256","DOI":"10.1016\/j.exphem.2024.104256","volume":"138","author":"J Straube","year":"2024","unstructured":"Straube J, Janardhanan Y, Haldar R, et al. Immune control in acute myeloid leukemia [J]. Exp Hematol. 2024;138:104256.","journal-title":"Exp Hematol"},{"issue":"1","key":"9803_CR36","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1038\/s41392-023-01605-2","volume":"8","author":"ZW Huang","year":"2023","unstructured":"Huang ZW, Zhang XN, Zhang L, et al. STAT5 promotes PD-L1 expression by facilitating histone lactylation to drive immunosuppression in acute myeloid leukemia [J]. Signal Transduct Target therapy. 2023;8(1):391.","journal-title":"Signal Transduct Target therapy"},{"issue":"1","key":"9803_CR37","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/s43018-022-00480-0","volume":"4","author":"A Lasry","year":"2023","unstructured":"Lasry A, Nadorp B, Fornerod M, et al. An inflammatory state remodels the immune microenvironment and improves risk stratification in acute myeloid leukemia [J]. Nat cancer. 2023;4(1):27\u201342.","journal-title":"Nat cancer"},{"issue":"7","key":"9803_CR38","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1038\/s41375-021-01253-x","volume":"35","author":"N Daver","year":"2021","unstructured":"Daver N, Alotaibi AS, B\u00fccklein V, et al. T-cell-based immunotherapy of acute myeloid leukemia: current concepts and future developments [J]. Leukemia. 2021;35(7):1843\u201363.","journal-title":"Leukemia"},{"issue":"11","key":"9803_CR39","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1182\/blood.2023021680","volume":"144","author":"F Mazziotta","year":"2024","unstructured":"Mazziotta F, Biavati L, Rimando J, et al. CD8\u2009+\u2009T-cell differentiation and dysfunction inform treatment response in acute myeloid leukemia [J]. Blood. 2024;144(11):1168\u201382.","journal-title":"Blood"},{"issue":"26","key":"9803_CR40","doi-asserted-by":"publisher","first-page":"2689","DOI":"10.1182\/blood.2023019961","volume":"143","author":"J Vadakekolathu","year":"2024","unstructured":"Vadakekolathu J, Rutella S. Escape from T-cell-targeting immunotherapies in acute myeloid leukemia [J]. Blood. 2024;143(26):2689\u2013700.","journal-title":"Blood"},{"key":"9803_CR41","doi-asserted-by":"crossref","unstructured":"Zhang X, Liu L. Senescent T Cells: The Silent Culprit in Acute Myeloid Leukemia Progression? [J]. Int J Mol Sci. 2024;25(23).","DOI":"10.3390\/ijms252312550"}],"container-title":["Immunologic Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-026-09803-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12026-026-09803-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-026-09803-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T02:11:23Z","timestamp":1788487883000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12026-026-09803-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,4]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["9803"],"URL":"https:\/\/doi.org\/10.1007\/s12026-026-09803-0","relation":{},"ISSN":["1559-0755"],"issn-type":[{"value":"1559-0755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,4]]},"assertion":[{"value":"28 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Ethics Committee of Inner Mongolia University. Each experiment was performed in accordance with the National Institute of Health Guide for the Care and Use of Laboratory Animals. The study was carried out in compliance with the ARRIVE guidelines (\n                      \n                      ).The study was approved by the Ethics Committee of Maternal and Child Health Care Hospital of the Inner Mongolia autonomous region, all methods were performed in accordance with the Declarations of Helsinki. Written informed consents were signed by all participants before the study.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"100"}}